QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
In many families, both prostate cancer and breast cancer are diagnosed among close relatives. However, the major breast cancer genes (BRCA1 and BRCA2) do not appear to explain the clustering of these two cancers within most of these families. Dr….
The 2013 American Urological Association (AUA) guidelines for the detection of prostate cancer are untenable for providing optimal care to men younger than 55 years or older than 69, or men at high risk for prostate cancer. Flawed and Incomplete…
Obesity is increasingly common in the U.S. It is associated with hypertension, diabetes, coronary heart disease and worse survival rates for many cancers. Obesity Increases the Risk of High-Grade Prostate Cancer New research led by Adriana Vidal, PhD, supports the…
A new study found that the use of aspirin and/or other nonsteroidal anti- inflammatory drugs (NSAIDs) was associated with a reduced risk of prostate cancer. Researchers followed 6,390 men who had a PSA of 2.5-10 ng/mL and a negative biopsy…
Specialized Programs of Research Excellence (SPOREs) are an integral part of the National Cancer Institute’s efforts to promote collaborative and interdisciplinary cancer research. The prestigious SPORE grants fund projects that will result in new and diverse approaches to the prevention,…
Arecent study suggested that vitamin D deficiencies could be a predictor of prostate cancer diagnoses and aggressiveness, especially among African American men. Researchers obtained serum vitamin D levels from 667 men aged 40-79 having prostate biopsies at Chicago urology clinics….
On June 20, URF Board president Anthony F. Sansone, Sr. was presented with the Lifetime Achievement Award at the Ernst and Young (EY) Entrepreneur Of The YearTM Award in the Central Midwest ceremony. The award recognized Mr. Sansone as an…
Researchers at the Harvard Medical School and the UCLA Medical Center evaluated the association between insurance status and prostate cancer outcomes in 85,203 men younger than 65 years diagnosed with prostate cancer. Their results underscored the importance of having access…
In the midst of the debate over PSA testing, the new National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer Early Detection aim to maximize the benefits and minimize the harms of PSA testing. These guidelines are important because many…
The Spring 2014 issue of QUEST reported that the FDA is reviewing the risk of stroke, heart attack and death in men taking testosterone products. The review was prompted by the publication of two studies that linked testosterone therapy and…
"*" indicates required fields
